Literature DB >> 32868752

No pain, still gain (of function): the relation between sensory profiles and the presence or absence of self-reported pain in a large multicenter cohort of patients with neuropathy.

Julia Forstenpointner1, Ruth Ruscheweyh2, Nadine Attal3, Ralf Baron1, Didier Bouhassira2, Elena K Enax-Krumova4, Nanna B Finnerup5,6, Rainer Freynhagen7,8, Janne Gierthmühlen1, Per Hansson9,10, Troels S Jensen5, Christoph Maier11, Andrew S C Rice12, Märta Segerdahl13,14, Thomas Tölle15, Rolf-Detlef Treede16, Jan Vollert12,16.   

Abstract

ABSTRACT: The pathophysiology of pain in neuropathy is complex and may be linked to sensory phenotypes. Quantitative sensory testing, a standardized method to evaluate sensory profiles in response to defined stimuli, assesses functional integrity of small and large nerve fiber afferents and central somatosensory pathways. It has revealed detailed insights into mechanisms of neuropathy, yet it remains unclear if pain directly affects sensory profiles. The main objective of this study was to investigate sensory profiles in patients with various neuropathic conditions, including polyneuropathy, mononeuropathy, and lesions to the central nervous system, in relation to self-reported presence or absence of pain and pain sensitivity using the Pain Sensitivity Questionnaire. A total of 443 patients (332 painful and 111 painless) and 112 healthy participants were investigated. Overall, loss of sensation was equally prevalent in patients with and without spontaneous pain. Pain thresholds were equally lowered in both patient groups, demonstrating that hyperalgesia and allodynia are just as present in patients not reporting any pain. Remarkably, this was similar for dynamic mechanical allodynia. Hypoalgesia was more pronounced in painful polyneuropathy, whereas hyperalgesia was more frequent in painful mononeuropathy (compared with painless conditions). Self-reported pain sensitivity was significantly higher in painful than in painless neuropathic conditions. Our results reveal the presence of hyperalgesia and allodynia in patients with central and peripheral lesions of the somatosensory system not reporting spontaneous pain. This shows that symptoms and signs of hypersensitivity may not necessarily coincide and that painful and painless neuropathic conditions may mechanistically blend into one another.
Copyright © 2020 International Association for the Study of Pain.

Entities:  

Mesh:

Year:  2021        PMID: 32868752     DOI: 10.1097/j.pain.0000000000002058

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  6 in total

Review 1.  Innovations and advances in modelling and measuring pain in animals.

Authors:  Katelyn E Sadler; Jeffrey S Mogil; Cheryl L Stucky
Journal:  Nat Rev Neurosci       Date:  2021-11-26       Impact factor: 38.755

2.  Mapping chemotherapy-induced peripheral neuropathy phenotype and health-related quality of life in patients with cancer through exploratory analysis of multimodal assessment data.

Authors:  Mian Wang; Alex Molassiotis
Journal:  Support Care Cancer       Date:  2022-01-21       Impact factor: 3.603

3.  Classification of Qualitative Fieldnotes Collected During Quantitative Sensory Testing: A Step Towards the Development of a New Mixed Methods Approach in Pain Research.

Authors:  Martine Bordeleau; Guillaume Léonard; Lynn Gauthier; Catherine Estelle Ferland; Miroslav Backonja; Jan Vollert; Serge Marchand; Philip Jackson; Léo Cantin; Michel Prud'Homme
Journal:  J Pain Res       Date:  2021-08-18       Impact factor: 3.133

4.  Mechanistically informed non-invasive peripheral nerve stimulation for peripheral neuropathic pain: a randomised double-blind sham-controlled trial.

Authors:  Selina Johnson; Anne Marshall; Walter Magerl; Andreas Goebel; Dyfrig Hughes; Emily Holmes; Florian Henrich; Turo Nurmikko; Manohar Sharma; Bernhard Frank; Paul Bassett; Andrew Marshall
Journal:  J Transl Med       Date:  2021-11-06       Impact factor: 5.531

5.  Local hyperexcitability of C-nociceptors may predict responsiveness to topical lidocaine in neuropathic pain.

Authors:  Gunther Landmann; Lenka Stockinger; Benjamin Gerber; Justus Benrath; Martin Schmelz; Roman Rukwied
Journal:  PLoS One       Date:  2022-07-14       Impact factor: 3.752

Review 6.  The history of pain measurement in humans and animals.

Authors:  Jeffrey S Mogil
Journal:  Front Pain Res (Lausanne)       Date:  2022-09-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.